| Authors: |
Hernández-Blanco C; Internal Medicine Department, University Hospital La Paz, Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Al-Akioui-Sanz K; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; CNIO Pediatric OncoHematology Clinical Research Unit, Madrid, Spain., Herrera L; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center of Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer 'REINCA' (RED2022-134831-T), Madrid, Spain., Aguirre-Portolés C; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; CNIO Pediatric OncoHematology Clinical Research Unit, Madrid, Spain., Lozano-Ojalvo D; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Food Science Research Institute (CIAL, CSIC-UAM), Madrid, Spain., Pérez-Rodriguez L; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cano-Ochando J; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Microbiology National Centre, Instituto de Salud Carlos III, Madrid, Spain., Guerra-García P; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Clinical Trials Unit (UCICEC), University Hospital La Paz, Madrid, Spain., Martín-Quirós A; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Vicario JL; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Santos S; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center of Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer 'REINCA' (RED2022-134831-T), Madrid, Spain., Pérez-Vaquero MÁ; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center of Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer 'REINCA' (RED2022-134831-T), Madrid, Spain., Vesga MÁ; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center of Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer 'REINCA' (RED2022-134831-T), Madrid, Spain., Borobia AM; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Clinical Trials Unit (UCICEC), University Hospital La Paz, Madrid, Spain., Carcas AJ; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Clinical Trials Unit (UCICEC), University Hospital La Paz, Madrid, Spain.; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain., Balas A; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Moreno MÁ; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Pérez de Diego R; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Gasior M; Hematology Department, Hospital Universitario La Paz, Madrid, Spain., Soria B; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Institute of Bioengineering, Miguel Hernández University, Elche, Alicante, Spain., Eguizabal C; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center of Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer 'REINCA' (RED2022-134831-T), Madrid, Spain., Pérez-Martínez A; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; CNIO Pediatric OncoHematology Clinical Research Unit, Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0024, RICORS RD24/0014/0025, RICORS RD21/0017/0025, RICORS RD24/0014/0024), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain.; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain. |
